Introduction
The existence of multiple forms or subtypes of opioid receptors was first suggested by Martin and colleagues (Gilbert and Martin, 1976; Martin et al., 1976) , using the chronic spinal dog preparation, and has since been supported by numerous behavioral, pharmacological, and receptor binding studies (Gillan and Kosterlitz, 1982; Wood, 1982; Goldstein and James, 1984; Herling and Woods, 1984; James and Goldstein, 1984) . Opioid receptors have been divided into at least three main classes: K, 6, and p. These receptors have unique pharmacological profiles, anatomical distributions, and functions in several species, including man (Wood, 1982; Simon, 1991; Lutz and Pfister, 1992; Mansour and Watson, 1993) . Several pharmacological agents as well as various members of the three endogenous opioid peptide families (prodynorphin, proenkephalin, and proopiomelanocortin) have been shown to interact with these receptors in distinctive and well-described manners.
K receptors have been shown to exist in diverse regions of the CNS; they are particularly enriched in the cortex, striatum, and hypothalamus (Mansour et al., 1987; Neck et al., 1988; Unterwald et al., 1991) and are thought to mediate many of the actions of the dynorphin peptide family in addition to those of benzomorphans.
These actions include the modulation of drinking, water balance, food intake, gut motility, temperature control, and various endocrine functions (Morley and Levine, 1983; Leander et al., 1985; lyengar et al., 1986; Manzanares et al., 1990) . 6 receptors are also found throughout the CNS, particularly in forebrain areas such as the striatum and cerebral cortex, and have been shown to bind enkephalin-like peptides (Mansour et al., 1988; Wood, 1988) . 6 receptors are also thought to modulate several hormonal systems and to mediate analgesia.
The p receptors represent the third member of the opioid receptor family.These receptors bind morphinelike drugs and several endogenous opioid peptides, including P-endorphin (derived from proopiomelanocortin) and several members of both the enkephalin and the dynorphin opioid peptide families. These receptors have been localized in many regions of the CNS, including the striatum (striatal patches), thalamus, nucleus tractus solitarius, and spinal cord (Mansour et al., 1987; McLean et al., 1986; Temple and Zukin, 1987; Wood, 1988; Mansour and Watson, 1993) . p receptors appear to mediate the opiate phenomena classically associated with morphine and heroin administration, including analgesia, opiate dependence, cardiovascular and respiratory depression, and several neuroendocrine effects. Pasternak and co-workers (Pasternak and Snyder, 1975; Wolozin and Pasternak, 1981; Pasternak and Wood, 1986; Pasternak, 1993) and Rothman and co-workers (Rothman et al., 1987) have suggested that p receptors can be subdivided into two classes, ~1 and ~2. ~1 receptors are thought to have high affinity for both morphine and enkephalins. In contrast, ~2 receptors selectively interact with morphine-like compounds and DAMGO ([D-AlaZ,N-MePhe4,Gly-o15]enkephalin).
These studies further suggest that ~1 and ~2 are functionally distinct: ~1 receptors, unlike ~2 receptors, apparently mediate analgesia but not respiratory depression or physical dependence (Pasternak, 1993) .
Owing to the importance of opioid receptors in opioid pharmacology and physiology, many researchers have attempted to purify these proteins with the aim of ultimately describing the molecular sequence of these receptors.
In one such attempt, Schofield reported the isolation of a protein (opioid-binding cell adhesion molecule) apparently involved with an opioid receptor (Schofield et al., 1989) . This protein has been shown to be a member of the immunoglobulin superfamily of cell adhesion molecules but lacks transmembrane domains, a feature assumed necessary for signal transduction.
Using an expression cloning strategy, Xie et al. (1992) (Simon et al., 1975; Bidlack and Abood, 1980; Ruegg et al., 1980; Simonds et al., -1980; Cho et al., 1981 Cho et al., , 1986 Howells et al., 1982; Chow and Zukin, 1983; Demoliou-Mason and Barnard, 1984; Maneckjee et al., 1985; Ueda et al., 1987) . Many of these reports suggest that this protein is approximately 40-60 kd. Additionally, this receptor can be functionally coupled to G proteins (Koski and Klee, 1981; Barchfeld and Medzihradsky, 1984; Hsia et al., 1984; Puttfarchen et al., 1988; Attali et al., 1989) . However, the low abundance of the protein and its apparently high hydrophobicity have proved to be major stumbling blocks for the sequencing of sufficiently long peptide fragments necessary for the molecular cloning of this receptor. Kieffer et al. (1992) and Evans et al. (1992) Evans et al. (1992) showed that activation of their receptor with selective 8 agonists could decrease CAMP levels in transfected COS cells. The mouse S receptors were found to be highly homologous to several members of the G proteincoupled receptor family, particularlythesomatostatin receptors. The cloning of the mouse 6 receptors facilitated the cloning of other members of the opioid receptor family. Recently, Yasuda and co-workers described the isolation of a mouse K receptor cDNA that had been isolated as a member of the related somatostatin receptor family (Yasuda et al., 1993) . Independently, our laboratory, using DNA fragments homologous to the mouse 6 opioid receptor and low stringency cDNA library screening, isolated and pharmacologically characterized a rat K receptor cDNA (Meng et al., 1993) . The rat and mouse K receptors contain seven transmembrane domains and are negativelycoupled toadenylatecyclase via G proteins. This report describes the cloning and characterization of a homologous seven transmembrane domain protein whose pharmacological profile and mRNA localization suggest that it is a rat t.r receptor.
Results

Isolation and Characterization
of Rat p Receptor cDNA Clones Using random primed cDNA from rat olfactory bulb and oligonucleotide primers (based upon transmembranedomains III,V,VI,andVIIofthemouse6opioid receptor mRNA [Evans et al., 1992; Kieffer et al., 1992] ), amplified fragments were generated by the polymerase chain reaction (PCR) and subcloned.
One clone, p5A-1, contained a DNA sequence that was 74% homologous at the nucleic acid level to the mouse8 opioid receptor mRNA sequence between transmembrane regions III and VI. The p5A-1 sequence was also similar (59% homology at the nucleic acid level) to several species of somatostatin receptor mRNAs. in part, seven hydrophobic domains. GenBank data base searches using both the amino acid and the nucleic acid sequences revealed that the pRMuR-12 sequence was novel and highly homologous to the mouse 6 opioid receptor (74% similar and 59.5% identical at the amino acid level) and the somatostatin receptors (60.5% similar and 39.5% identical at the amino acid level). As can be seen in Figure  1, (1.6 nM) was used as a labeling ligand, and various IL-, 6-, and K-selective ligands and nonselective ligands were tested in competition studies (Table 1) . Several classic p-selective ligands had high affinities for the expressed receptor (morphine, K, = 7.14 nM; levorphanol, Ki = 0.78 nM), whereas 6 (DSLET [(D-Ser2, LeuS)enkephalin-Thr], K, = 541.63 nM; DPDPE, K, = 4,100.OO nM) and K 
benzene acetamide methanesulfonate], K, = 1464.00 nM; U69,593, Ki = 1910.00 nM) ligands did not. DADLE (o-Ala-o-Leu-enkephalin; Ki = 6.56 nM) and the synthetic dynorphin
Several antagonists were also tested. Naloxone (Ki = 2.74 nM), naltrexone (K, = 0.36 nM), CTAP (D-Pen-CysTyr-D-Trp-Arg-Thr-Pen-Thr-NH?; Ki = 0.21), and nBNl (nor-binaltrophine
binding with high affinity. The expressed receptor also bound several nonselective opioid ligands such as (-)bremazocine (K, = 0.05 nM) and EKC (ethylketoclazocine; Ki = 1.28 nM) with high affinity. Furthermore, ligand binding to the transiently expressed receptor clone was stereospecific.
(-)Brema- zocine and levorphanol bound with high affinity, but their enantiomers, (+)bremazocine and dextorphan, respectively, bound with low affinity.
Northern Blot Analysis of p Receptor mRN.4 Figure 2 show results from total RNA and poly(A) RNA from rat medullalpons as well as poly(A) RNA from humanSY5Ycells(6~gforSY5Yand10~gformedulla/ pons) electrophoresed on 16% formaldehyde-agarose (1%) gels hybridized with cRNA probes complementary to p5A-1. Blots were hybridized and washed at high stringency.
Lane 1 represents a short photographic exposure of the SY5Y mRNA lane (lane 2). Lanes2and3arefroma44 hrautoradiogramdetecting a single mRNA species in the rat medulla/pans mRNA sample and one prominent mRNA species in the human SY5Y cellular mRNA sample. Although less clear, analysis of total RNA from rat medulla/pans tissue (lane 4) identified a p receptor RNA species that comigrated with the band seen in the poly(A) RNA (lane 3). These mRNAs are approximately 12,000-14,000 and 14,000-16,000 nucleotides in length, respectively. Figure 3 show results from analysis of rat genomic DNA (20 pg per restriction enzyme diges#t) digested with restriction enzymes, electrophoresed on 0.8% agarose gels, and hybridized with random hexamer- Rat genomic DNA (20 ug per restriction enzyme digest) was digested with the indicated enzymes. Random hexamer priming of the full 2.0 kb cDNA from pRMuR-I2 was used as a probe. Blots were washed in decreasing SSC solutions (final concentrations of 0.1 x SSC, 0.5% SDS) at 60°C for 30 min. Exposures were performed using two intensifying screens at -70°C for 48 hr. Molecular weights were determined using an DNA ladder (BRL).
Genomic Southern Blot Analysis
studies. A thin layer of cells expressing the p receptor mRNA was observed in the deepest extents of layer VI, and no cells were detectable in layers I and IV, as was demonstrated with receptor binding. Low levels of l.r receptor mRNA could be detected in the piriform and cingulate cortex and the deep layer of the entorhinal cortex. v receptor mRNA was expressed at high levels in the striatal patches and the subcallosal streakventral to the corpus callosum ( Figure 4A ). The f.r striatal patches were most prominent in the rostra1 and lateral extents of the caudate-putamen and extended ventrally into the nucleus accumbens, where theywere the most dense in the medial and ventral shell. Specific hybridization was also observed in the striatal matrix; however, expression levels were comparatively reduced. More laterally, the cells of the medial septum expressed high levels of u receptor mRNA. Scattered cells expressing high levels of f.r receptor mRNA were seen in the bed nucleus stria terminalis , and (C) are sections through three levels of the brain. p receptor mRNA is expressed in the striatal patches of the caudate-putamen (CPU) and nucleus accumbens (ACB), subcallosal streak, olfactory tubercle, several nuclei of the thalamus, including the medial habenula (Hb), the medial dorsal (MD), and the central (CM) nuclei, hippocampus (HPC), dentate gyrus, basolateral amygdala, medial amygdala (Me), locus ceruleus (LC) and parabrachial nucleus (PB mRNA. As can be seen in Figure 5B , the highest density of cells expressing u receptor mRNA were in the rostra1 division, with scattered cells in the central division.
The levels of p receptor mRNA expression in the lateral interpeduncular nucleus was low compared with other subdivisions. Several brain stem nuclei expressed ).I receptor mRNA. Highest levels were observed in the locus ceruleus and parabrachial nuclei ( Figure 4C ; Figure 5C ). This distribution was consistent with the ability of (Figure 6 ). Figure 6A shows a low magnification in situ hybridization image of the u receptor mRNA distribution in the medulla, with the gracilis, vagus, and cuneate nuclei highlighted in boxes. As can also be seen from Figure 6A , the large cells of the medulla reticular nucleus also expressed u receptor mRNA.
In the spinal cord, the highest levels of opioid receptor binding were found in layers I and II, and only very low levels of u receptor mRNA could be found in the spinal cord. However, as can be seen in the coronal section of spinal cord in which the dorsal root ganglia were also transected, high levels of p receptor mRNA were found in the cells of the dorsal root ganglia that project to layers I and II of the dorsal horn (Figure 7) .
To control for potential cross-hybridization between this u receptor cDNA sequence and other closely related receptors (K and 6 opioid receptors and somatostatin receptors), cRNA probes directed to different regions of the pRMuR-12 protein (both to transmembrane domains Ill-VI and to the 5' untranslated/Nterminus regiomwere used. In both cases, cRNA probes revealed indistinguishable mRNA distributions.
Discussion
The results of the present study demonstrate that we have cloned a novel member of the G protein-coupled receptor family that can be identified as a rat j.r opioid receptor. This conclusion is based on the following observations: First, the cloned receptor interacts with several classic opioid ligands, such as morphine, naltrexone, naloxone, levorphanol, and bremazocine, and their relative affinities are consistent with its opioid nature. Second, binding data show that the protein encoded by pRMuR-12 has a high affinity for the u agonist DAMGO and the u antagonist CTAP, whereas it has very low affinity for K-selective U50,488 and U69,593 and S-selective DPDPE. Third, the receptor exhibits the predicted stereospecificity, recognizing (-)bremazocine and levorphanol with affinities several orders of magnitude higher than the affinities for their respective enantiomers, (+)bremazocine and dextrorphan.
Fourth, the rank orders of agonist and antagonist binding are consistent with previously described in vivo pharmacology reported for p receptors.
Finally, the anatomical distribution of the mRNA coding for this receptor is in agreement with the distribution of u receptor binding as defined with pharmacological ligands. Taken together, these results provide compelling evidence that the present clone encodes a rat u opioid receptor.
Several reports have suggested the presenceof multiple receptor subtypes referred to as ~1 and ~2. ~1 receptor sites are defined as having high affinity (below 1 nM) for the p and 6 ligands DAMGO, morphine, DADLE, and DSLET and may be preferentially important in mediating analgesia. ~2 sites are defined by the ability of these same compounds to bind with lower affinity (I-IO nM), with DAMGO having the highest affinity and morphine and DADLE having slightly lower affinities. If one accepts this classification, our cDNA clone appears to fit best with the ~2 subtype of p receptors. Until a second p receptor type is isolated and cloned, these assignments should remain tentative.
It was interesting to note that nBNI, the K-selective antagonist, has a high affinity for the transiently expressed rat p receptor. However, this should be viewed in relation to the affinity of nBNl for the cloned K receptor. When the rat K receptor is transiently transfected into COS-1 cells, nBNl demonstrates approximately II-fold greater affinity for the rat K receptor (Ki = 0.26 nM for K versus K, = 2.87 nM for p) (Meng et al., 1993) . These results compare well with nBNl's relative lack of selectivity in in vitro binding studies and point to the usefulness of comparing the pharmacology of opioid ligands in transiently transfected cell systems expressing an individual receptor.
Amino acid sequence comparisons of all three opioid receptors indicated that the p receptor has a high degree of homology with the recently cloned mouse 6 and rat K opioid receptors. The most homologous regions are the transmembrane domains and the intracellular loops. Putative transmembrane domains II, III, and VII are very similar among the three opioid receptors, followed by transmembrane domains I, V, and VI, with transmembrane IV being the least conserved.The highdegreeof homologyamonetheintr+ is particularly striking and may be useful not only for discriminating opioid from nonopioid receptors (e.g., opioid from somatostatin), but also for discriminating opioid receptor types (K from 6 from p), as several of these regions are thought to be on the extracellular surface of the protein and may be involved in ligand selectivity.
The notion that such extracellular domains may play an important role in determining ligand binding and ligand selectivity for peptide receptors was elegantly demonstrated in a series of studies on luteinizing hormone and folliclestimulating hormone receptors (Braun et al., 1991; Roche et al., 1992) .
Rat u receptor mRNA detected by Northern blot analysis is shown in Figure 2 . Analysis of total RNA from many regions of the rat brain generated weak signals but indicated thatthe medulla/pans contained the greatest amount of p receptor mRNA and was chosen for poly(A) mRNA purification.
A single large molecular weight mRNA of approximately 12,000-14,000 nucleotides was detected in this poly(A) RNA from the medulltipons. Human SY5Y cellular mRNA was also analyzed because of the presence of p receptors in this cell line (as well as S receptors).
It appears that a prominent mRNA of approximately 14,000-16,000 nucleotides is detected in this human cell line in addition to several other smaller mRNA species. It is unclear at this time whether these additional mRNAs are u receptor forms or represent nonspecific hybridization, even though these blots were hybridized at high stringency. We are currently using DNA fragments from different regions of the rat p receptor cDNA to determine whether these fragments identify the same mRNA species in this human cell line. It is interesting to note that in the g-expressing cell line NC108 five to six mRNA species were detected, although it appears that only two mRNAs are found in brain tissue.
Genomic Southern blot analysis of rat DNA using thefull cDNA isolated from pRMuR-12 (approximately 2.0 kb) indicates several interesting features of the structure of the rat u receptor gene. First, the hybridization pattern in the BamHl and Pstl digests is consistant with the hypothesis that a single p receptor gene exists in the rat genome.
Second, there appears to be several introns separating the 2.0 kb cDNA. This is deduced from the multiple hybridization-positive bands in the EcoRl and Hindlll digest lanes seen in Figure3. Thereare noEcoRl sitesandonlyone Hindlll site in the 2.0 kb cDNA fragment used as a hybridization probe, although several hybridization-positive bands are detected. Approximately, three to five bands are detected in the EcoRl lane, and five bands are detected in the Hindlll lane,although onecannot rule out the possibilitythat some of these bands represent incomplete enzyme digests. In isolating cDNA clones encoding the rat p receptor, one unusual cDNA clone appeared to contain an intron near the transmembrane IV location. Whether this cDNA clone contains an authentic intron or represents a cloning artifact is currently being evaluated. Interestingly, the mouse S opioid receptor gene has an intron in a very similar location (Evans, personal communication). Isolation and characterization of rat genomic clones will address the complete structure of the ).I receptor gene. ~1 receptor mRNA is expressed in many regions and nuclei throughout the CNS. The high level of pRMuR-12 mRNA in theolfactory bulb, striatal patches, subcallosal streak, thalamus, medial preoptic area, amygdala, interpeduncular, locus cerulus, parabrachial, cuneate, gracilis, and vagus nuclei, as well as in the nucleus of the solitarytract, isconsistentwith the known p-binding site distribution (Mansour et al., 1987; Mansour and Watson, 1993; McLean et al., 1986; Temple and Zukin, 1987) and used in PCR. Primer 1 (TM 3), AAGAATTCTCAACATCATGAGCCTGCACCCCTACCCTAC; primer 2 (TM S), AAGAATTCCCAACCTGCTCCCGATCCTCAT-CATC; primer 3 (TM 6), AAAAGCTTCCACACCATGACGAAGAT-CTGCATCGC; primer 4 CTM 7), AAAACCTTITAACGGGAACGT-CGGGTAGGTCAGGCGGCAGCCCCACC.
The PCR DNA templatewas first strand cDNA from rat olfactory bulb mRNA generated with random hexamers using the Promega RiboClone cDNA Synthesis system. The PCR products were subcloned into a T-tailed vector system (Novagen) and sequenced using Sequenase (USB kits. Poly(A) RNA (6 pg for 'SYSY and 10 pg for medulltipons) was electrophoresed on 16% formaldehydeagarose (1%) gels, transferred to nylon membrane (Nytran, Schleicher & Schuell, Inc.), UV cross-linked, prehybridized (2 hr), and hybridized (overnight) at 60°C in 50% formamide, 1 x HYB buffer (5x SSC, 50 mM NaP04 [pH 7.41, 0.1% NaPPOd, 5x Denhardt's solution, 0.5% SDS). cRNA probes complementary to pSA-1 (see text) were generated using standard transcription methods and T7 RNA polymerase.
Approximately, 2 x IO6 cpms of cRNA were used per ml of hybridization solution. Blots were washed in progressively decreasing SSC solutions, with final concentrations of 0.1 x SSC, 0.5% SDS, at 72°C for 2 hr. DNA was isolated from rat liver tissue, crushed on liquid N2, resuspended in proteinase K buffer (50 mM Tris [pH 7.51, 0.5% SDS, 5 mM IiDTA), digested for 3 hr, and gently extracted several times with phenol prior to RNAase treatment. These nucleic acid samples were reextracted with phenol-chloroform and ethanol precipitated. DNA was digested overnightwith the indicated enzymes under manufacturer's recommended conditions. These digests were emlectrophoresed on 1 x Tris borate EDTA, 1% agarose gels, acid nicked (30 min, 0.25 M HCI), denatured (2 x 30 min; 0.5 M NaOH, 1.5 M NaCI), neutralized (2 x 30 min; 0.5 M Tris [pH 7.41, 1.5 M NaCI), and transferred to nylon membranes (Nytran, Schleicher & Schuell, Inc.)inlOx SSCovernight. BlotswereUVcross-linkedand baked at80°C undervacuum for 1.5 hr, prehybridized (21 hr), and hybridized at 37OC in 50% formamide, 1 x HYB buffer (see above) overnight. Random hexamer priming of the full 2.0~ kb cDNA from pRMuR-12 was used as a probe at a concentration of 1.0 x IO6 cpm per ml of hybridization buffer. Blots were washed in de-creasing SSC solutions (final concentrations of 0.1 x SSC, 0.5% SDS) at 60°C for 30 min.
In Situ Hybridization Adult male Sprague-Dawley rats (20-25 g; Charles River) were sacrificed by decapitation.
The brains were then dissected and frozen in liquid isopentane (-3OOC) for 30 s and transferred to dry ice. Frozen brains were stored at -80°C until sectioning on a Bright cryostat (15 urn). Brain sections were thaw mounted on precleaned and polylysine-subbed microscope slidesand stored at -80°C.
Frozen brain sections were directly removed from storage at -80°C and placed into 4% formaldehyde for 60 min (22°C) prior to processing for in situ hybridization (Mansour et al., 1990) . Following three 5 min rinses in 2x SSC (300 mM NaCI, 30 mM sodium citrate [pH 7.2]), sections were treated with proteinase K (1 Kg/ml in 100 mM Tris [pH 8.01, 50 mM EDTA) for 10 min at 37OC. Slides were then rinsed in water, followed by 0.1 M triethanolamine (pH 8.0), and treated with a mixture of 0.1 M triethanolamine (pH 8.0) and acetic anhydride (400:1, v/v) with stirring for 10 min. The sections were then rinsed in water, dehydrated through graded alcohols, and allowed to air dry. Rat brain sections were hybridized with [3SS]UTP-and [3SS]CTPlabeled riboprobes generated to the pRMuR-12 clone. The TV receptor cRNA was generated from a PCR fragment subcloned into pCEM4Z (designated p5A-1) and corresponds to transmembrane regions III-VI of the receptor. As p5A-1 was produced using mouse 8 opioid receptor mRNA primers, we also used a 759 bp EcoRI-BamHI cDNA fragment derived from the 5' region of the pRMuR-12 cDNA clone. These two probes generated indistinguishable mRNA distributions.
cRNA probe was diluted in hybridization buffer(75% formamide, 10% dextran sulfate, 3x SSC, 50 mM Na2P0, [pH 7.4],1 x Denhardt's solution, 0.1 Fgiml yeast tRNA, 10 mM dithiothreitoi)
to give a final concentration of 1 x IO6 to 2 x IO6 cpmi30 ~1. Diluted probe was applied to coronal (40 ul) and horizontal (100 ul) sections. Glass coverslips were placed over brain sections to keep cRNA probes and hybridization buffer in contact with tissue.
Slides were then transferred to chambers containing 50% formamide and hybridized at 55"C, overnight. The slides were then rinsed in 2x SSC (5 min) and treated with RNAase A (200 ugi ml in 100 mM Tris [pH 8.01, 0.5 M NaCI) for 60 min at 37OC. Subsequently, the sections were rinsed in 2x SSC for 5 min (22OC) and 0.1 x SSC for 60 min (65°C). Following the low salt wash, sections were rinsed in water, and dehydrated through graded alcohols, and air dried. Sections were apposed to Kodak XAR-5 X-ray film for 1-11 days or dipped in NTB2 film emulsion and developed 3-14 days later.
